Warning About 'Normal' CA-125 for Recurrent Ovarian Cancer

"Eye-opening" findings challenge current NCCN guidelines | ASCO Reading Room Article Selection Thursday, February 29, 2024 FEATURED STUDY [Warning About 'Normal' CA-125 for Recurrent Ovarian Cancer]( ["Eye-opening" findings]( challenge current [NCCN guidelines]( Other Key News [Portable Device Pinpoints Tiny Breast Tumors]( ["Intelligent Breast Exam" can aid in resource-limited areas]( [Good News About These Combo Therapies for RCC]( [Revelations from ASCO's CancerLinQ database]( [How Machine Learning Is Helping Predict Lung Cancer Recurrence]( ["Objective, personalized, and reproducible" identification of relapse]( [Promising Treatment for Bladder Cancer Is Way Too Expensive]( [Integration of immunotherapy]( in perioperative setting with [ICIs, small molecules, and ADCs]( © 2024 MedPage Today, LLC. MedPage Today is among the federally registered trademarks of MedPage Today, LLC, and may not be used by third parties without explicit permission. You have received this email because you have registered to receive emails at www.medpagetoday.com, with the email address: {EMAIL} [Manage Email Preferences]( | [Unsubscribe](lst=NL_Partner_ASCO_Reading_Room) | [Terms of Use]( | [Privacy Policy]( Technical Questions: feedback@medpagetoday.com 114 Fifth Avenue 15th Floor New York, NY 10011